Form SC14D9C NGM BIOPHARMACEUTICALS Filed by: NGM BIOPHARMACEUTICALS INC

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/19/2026

1. MRNA
2. KLAR
3. KEYS
4. PANW
5. SPY
6. MRK
7. HD
8. DVLT
9. MRCY
10. LOW

Go back to Form SC14D9C NGM BIOPHARMACEUTICALS Filed by: NGM BIOPHARMACEUTICALS INC

Citi Downgrades NGM Biopharmaceuticals (NGM) to Neutral

February 27, 2024 8:47 AM EST

Citi analyst Samantha Semenkow downgraded NGM Biopharmaceuticals (NASDAQ: NGM) from Buy to Neutral with a price target of $1.55 (from $6.00).

The analyst comments "NGM announced the company has entered into a merger agreement with affiliates of The Column Group (i.e., Atlas Neon... More